Please login to the form below

Not currently logged in
Email:
Password:

Dr Christian Itin joins Cytos Biotechnology as CEO

He moves to the Swiss biotech from Micromet

Cytos Biotechnology CEO Dr Christian ItinSwiss biotech company Cytos Biotechnology has appointed Dr Christian Itin to be its new CEO.

He has also been elected to Cytos' board of directors and will be proposed as its new chairman, succeeding Dr Thomas Hecht, at an extraordinary shareholders meeting next month.

Dr Itin joins Cytos from Micromet, where he served as CEO for eight years until the biopharmaceutical company was acquired by Amgen earlier this year for $1.2bn.

In total he spent 13 years in senior management roles at Micromet, prior to which he co-founded US protein chip company Zyomyx.

Commenting on the appointment Dr Hecht said: “Christian is an experienced biotech leader with significant expertise and a proven track record and his appointment completes our restructuring of Cytos. We believe with his experience and skills that he is well positioned to shape Cytos' future.” 

Cytos' board will see a further change next month, when non-executive member, and its former chief financial officer Jakob Schlapbach will set down at the shareholder meeting.

18th October 2012

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics